Navigation Links
Amicus Therapeutics to Present at the BIO CEO & Investor Conference 2008
Date:2/7/2008

CRANBURY, N.J., Feb. 7 /PRNewswire-FirstCall/ -- Amicus Therapeutics Inc. (Nasdaq: FOLD), today announced that John F. Crowley, President and Chief Executive Officer, will present a corporate update at BIO CEO & Investor Conference 2008 in New York, NY on Monday, February 11, 2008 at 12:30 pm (Eastern Standard Time) at the Waldorf-Astoria Hotel.

The presentation will be webcast live and may be accessed by visiting Amicus' website at http://www.amicustherapeutics.com. A replay of the webcast will also be available on the Company's website until February 25, 2008.

About Amicus Therapeutics

Amicus Therapeutics is a biopharmaceutical company developing novel, oral therapeutics known as pharmacological chaperones for the treatment of a range of human genetic diseases. Pharmacological chaperone technology involves the use of small molecules that selectively bind to and stabilize proteins in cells, leading to improved protein folding and trafficking, and increased activity. Amicus is initially targeting lysosomal storage disorders, which are severe, chronic genetic diseases with unmet medical needs. Amicus has completed Phase 2 clinical trials of Amigal for the treatment of Fabry disease and is conducting Phase 2 clinical trials of Plicera(TM) for the treatment of Gaucher disease. The Company has completed Phase 1 clinical trials of AT2220 for the treatment of Pompe disease.

Forward-Looking Statements

Amicus cautions you that statements included in this press release that are not a description of historical facts are "forward-looking statements" within the meaning of Section 21E of the Private Securities Litigation Reform Act of 1995. Words such as,
'/>"/>

SOURCE Amicus Therapeutics Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Amicus Therapeutics to Present at the Merrill Lynch Global Pharmaceutical, Biotech & Medtech 2007 Conference
2. Amicus Therapeutics Announces Third Quarter 2007 Financial Results
3. Meredith Martin Addy Named Chair of AIPLAs Amicus Committee
4. Amicus Therapeutics to Present at the Lazard Capital Markets Fourth Annual Healthcare Conference
5. Amicus Therapeutics to Host R&D Day
6. Amicus Therapeutics Announces Positive Results From Phase 2 Clinical Trials of Amigal(TM) for Fabry Disease
7. Amicus Therapeutics Announces Fourth Quarter and Full Year 2007 Financial Results & Program Advancements
8. Amicus Therapeutics to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference
9. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
10. DJO Incorporateds Pending Merger With ReAble Therapeutics Clears U.S. Antitrust Review
11. PeriCor Therapeutics Announces Closing of Licensing Agreement for Acadesine with Schering-Plough Corporation

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009)... Leader Richard Gephardt Brings Together A-List fr...ties for "Best and Brightest Forum on Medical Inn...wire-USNewswire/ -- Several of New Jersey,s most p...medicine and technology gathered today at the Libe...dical innovation in New Jersey, and throughout the...
(Date:12/1/2009)...1 The Burrill Biotech Select Index...t in October. The Select,s gain of 4.5 percent mir...eral markets with the Dow up 6.5 percent and the N... in the final two trading days of the month despit...iday shopping and Dubai,s reported debt woes. ,...
(Date:12/1/2009)... 1 Palatin Technologies,...U.S. Patent and Trademark Office has issued U.S. P...ptide Constructs." The claims in the issued paten...natriuretic peptide receptor A (NPRA), including P...e. ,, "Our natriuretic compounds, including PL-...
(Date:12/1/2009)...China, Dec. 1 /PRNewswire-Asia-FirstCall/ -- China... "the Company") (Nasdaq: CSKI ), a leading,fully ...roducing,over-the-counter drugs in the People,s Re...Company has engaged Guangdong Mediacy Kind Medical... as its exclusive sales agent for the,Company,s AM...
Breaking Biology Technology:New Jersey's Best and Brightest Minds Discuss Challenges Facing Medical Innovation, Call for Policies to Preserve U.S. Leadership in Research and Development 2New Jersey's Best and Brightest Minds Discuss Challenges Facing Medical Innovation, Call for Policies to Preserve U.S. Leadership in Research and Development 3New Jersey's Best and Brightest Minds Discuss Challenges Facing Medical Innovation, Call for Policies to Preserve U.S. Leadership in Research and Development 4New Jersey's Best and Brightest Minds Discuss Challenges Facing Medical Innovation, Call for Policies to Preserve U.S. Leadership in Research and Development 5Biotech Gets Back on Track in November 2Biotech Gets Back on Track in November 3Biotech Gets Back on Track in November 4Palatin Technologies, Inc. Issued U.S. Patent for Heart Failure Drug Candidate 2Palatin Technologies, Inc. Issued U.S. Patent for Heart Failure Drug Candidate 3China Sky One Medical, Inc. Signs Distribution Agreement with MDK for the Sale of Two Diagnostic Kits in Southeast Asia 2China Sky One Medical, Inc. Signs Distribution Agreement with MDK for the Sale of Two Diagnostic Kits in Southeast Asia 3
...ward by the Association of Chi...Newswire-FirstCall/ - ARIUS Research Inc. (TSX:,AR...ping the next wave of,antibody therapeutics, today...Chief Executive Officer, received the "Most Innova...wards, held on April 5th, 2008 in Toronto,Ontario....
... have used graphene to measure an important and my...undations of the universe. , The researchers from...ssor Andre Geim, have found that the worlds thinne...ible light, which allows the direct determination ...rtuguese theorists from The University of Minho in...
...uticals Corp. (Nasdaq: MEMY ) today announced tha...daq Stock Market stating that the Company is,no lo...stockholders, equity,requirement for continued lis... Rule 4450(a)(3). As reported in the Company,s Ann...r 31, 2007, the Company,s stockholders,equity was ...
Other Biology Technology:ARIUS recognized for entrepreneurial excellence 2Graphene gazing gives glimpse of foundations of universe 2Memory Pharmaceuticals Receives Nasdaq Notification 2Memory Pharmaceuticals Receives Nasdaq Notification 3
(Date:12/1/2009)...fferent feeding strategies. A large proportion of...are generalist predators feeding on other small an...er, are "herbivorous". This is not to say that th...s consist of plant-derived matter. For example, so...ttract ants, called extra-floral nectar; others fe...
(Date:12/1/2009)...man . , Brown adipose tissue is different from...a, miniature power stations which among other thin...nerate a voltage similar to that of a battery, whi...wever, the mitochondria of brown fat cells have a ...me. The energy released when the fat is broken dow...
(Date:12/1/2009)...acks by sharks can be solved with a new technique ...hey put on their victims, according to a Universit... method analogous to analyzing human fingerprints,...comparing shark bites to the jaws and teeth of the... of the International Shark Attack File, which is ...
Breaking Biology News(10 mins):Bacterial gut symbionts are tightly linked with the evolution of herbivory in ants 2Brown fat cells make 'spare tires' shrink 2New forensic technique gives clues about sharks from bite damage 2New forensic technique gives clues about sharks from bite damage 3Comparative Effectiveness Research Study in Mayo Clinic Proceedings Demonstrated Asthma Patients Had Better Overall Results with Oral Controllers than 55398 1Comparative Effectiveness Research Study in Mayo Clinic Proceedings Demonstrated Asthma Patients Had Better Overall Results with Oral Controllers than 55398 2Comparative Effectiveness Research Study in Mayo Clinic Proceedings Demonstrated Asthma Patients Had Better Overall Results with Oral Controllers than 55398 3Comparative Effectiveness Research Study in Mayo Clinic Proceedings Demonstrated Asthma Patients Had Better Overall Results with Oral Controllers than 55398 4PRA International to Host Audio Conference 55394 1PRA International to Host Audio Conference 55394 2AED School Program at Its Best 3A Atlanta Public Schools Partnership With Cardiac Science 55390 1AED School Program at Its Best 3A Atlanta Public Schools Partnership With Cardiac Science 55390 2AED School Program at Its Best 3A Atlanta Public Schools Partnership With Cardiac Science 55390 3AED School Program at Its Best 3A Atlanta Public Schools Partnership With Cardiac Science 55390 4AED School Program at Its Best 3A Atlanta Public Schools Partnership With Cardiac Science 55390 5AED School Program at Its Best 3A Atlanta Public Schools Partnership With Cardiac Science 55390 6AED School Program at Its Best 3A Atlanta Public Schools Partnership With Cardiac Science 55390 7
...ersity researchers have developed a synthetic wood...eenhouse gas emissions and shrink landfills. , Th...stic that could be used in a variety of building m...stics now used in billions of disposable water bot...ucts that serve a societal need and respect and pr...
... is available in German . , , The gene Myc is a...cell division. It causes the production of a prote...expression of up to 15 % of all human genes. When ...rates excessively and apoptosis is inhibited. Ther...ent of many tumors. The problem is that pharmacolo...
...osium on Multimodality Cardiovascular Molecular Im...es in stem cell therapy, leading-edge research in ...diovascular system, including imaging of cardiovas...bolism and myocardial repair. , SNM and the Inte...ase will host a satellite meeting devoted to FDA r...
Other Biology News:Stanford researchers develop biodegradable substitutes for wood, plastic bottles and other materials 2Stanford researchers develop biodegradable substitutes for wood, plastic bottles and other materials 3SNM Symposium on Multimodality Cardiovascular Molecular Imaging 2
RapidStak from Thermo Scientific
Small bottle, 150 x 35mm from Thermo Scientific
...erful technology platform that automates gel proce... quality sample preparation can be carried out by ...hnology platform that automates gel processing for...e functions of high-resolution gel imaging, precis...
...h any of UVP's Doc-It systems. When further analys...re onto your existing computer. Doc-It software o...t tools. Doc-It 1D Analysis Software provides auto...nd accurate electrophoresis analysis., Enhan...
Biology Products: